These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29128155)

  • 21. Minor splicing pathway is not minor any more: implications for the pathogenesis of motor neuron diseases.
    Onodera O; Ishihara T; Shiga A; Ariizumi Y; Yokoseki A; Nishizawa M
    Neuropathology; 2014 Feb; 34(1):99-107. PubMed ID: 24112438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frontotemporal dementia and motor neuron disease: report of 3 cases in Taiwan and literature review.
    Chen KH; Chiu MJ; Cheng TW; Su JJ
    Acta Neurol Taiwan; 2011 Sep; 20(3):202-8. PubMed ID: 22009125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder.
    Vázquez-Costa JF; Arlandis S; Hervas D; Martínez-Cuenca E; Cardona F; Pérez-Tur J; Broseta E; Sevilla T
    J Neurol Sci; 2017 Jul; 378():130-136. PubMed ID: 28566149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic disorders of motor neurons.
    Cole N; Siddique T
    Semin Neurol; 1999; 19(4):407-18. PubMed ID: 10716663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chorea-ballism associated with familial amyotrophic lateral sclerosis. A clinical, genetic, and neuropathological study.
    Gamez J; Corbera-Bellalta M; Mila M; López-Lisbona R; Boluda S; Ferrer I
    Mov Disord; 2008 Feb; 23(3):434-8. PubMed ID: 18072201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALS and other motor neuron diseases.
    Tiryaki E; Horak HA
    Continuum (Minneap Minn); 2014 Oct; 20(5 Peripheral Nervous System Disorders):1185-207. PubMed ID: 25299277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slowly progressive motor neuron disease with multi-system involvement related to p.E121G SOD1 mutation.
    Taieb G; Polge A; Juntas-Morales R; Pageot N; Lumbroso S; Mouzat K; Camu W
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):296-297. PubMed ID: 27892702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors.
    Woodruff TM; Costantini KJ; Taylor SM; Noakes PG
    Adv Exp Med Biol; 2008; 632():143-58. PubMed ID: 19025120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor neuron disease: current management and future prospects.
    Simon NG; Huynh W; Vucic S; Talbot K; Kiernan MC
    Intern Med J; 2015 Oct; 45(10):1005-13. PubMed ID: 26429216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases.
    Hübers A; Marroquin N; Schmoll B; Vielhaber S; Just M; Mayer B; Högel J; Dorst J; Mertens T; Just W; Aulitzky A; Wais V; Ludolph AC; Kubisch C; Weishaupt JH; Volk AE
    Neurobiol Aging; 2014 May; 35(5):1214.e1-6. PubMed ID: 24378086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reappraisal of amyotrophic lateral sclerosis with dementia].
    Murakami N; Yoshida M
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1560-2. PubMed ID: 8752463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.
    Winner B; Marchetto MC; Winkler J; Gage FH
    Hum Mol Genet; 2014 Sep; 23(R1):R27-34. PubMed ID: 24821704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A molecular genetic approach to amyotrophic lateral sclerosis.
    Siddique T; Hu P; Hentati A; Deng G; Hung WY; McInnis MG; Warren AC; Rimmler J; Antonarakis S; Pericak-Vance MA
    Int J Neurol; 1991-1992; 25-26():60-9. PubMed ID: 11980064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular genetics of non-ALS motor neuron diseases.
    James PA; Talbot K
    Biochim Biophys Acta; 2006; 1762(11-12):986-1000. PubMed ID: 16765570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
    Angelov DN; Waibel S; Guntinas-Lichius O; Lenzen M; Neiss WF; Tomov TL; Yoles E; Kipnis J; Schori H; Reuter A; Ludolph A; Schwartz M
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4790-5. PubMed ID: 12668759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor Neuron Disease: New insights into genetic risk factors for amyotrophic lateral sclerosis.
    Malkki H
    Nat Rev Neurol; 2016 Sep; 12(9):491. PubMed ID: 27492589
    [No Abstract]   [Full Text] [Related]  

  • 37. Motor neuron disease due to neuropathy target esterase gene mutation: clinical features of the index families.
    Rainier S; Albers JW; Dyck PJ; Eldevik OP; Wilcock S; Richardson RJ; Fink JK
    Muscle Nerve; 2011 Jan; 43(1):19-25. PubMed ID: 21171093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary lateral sclerosis may occur within familial amyotrophic lateral sclerosis pedigrees.
    Praline J; Guennoc AM; Vourc'h P; De Toffol B; Corcia P
    Amyotroph Lateral Scler; 2010; 11(1-2):154-6. PubMed ID: 20184517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurometabolic disorders are treatable causes of dystonia.
    Kuiper A; Eggink H; Tijssen MA; de Koning TJ
    Rev Neurol (Paris); 2016; 172(8-9):455-464. PubMed ID: 27561437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings of the 6th International Symposium on Motor Neuron Disease and Amyotrophic Lateral Sclerosis. Dublin, Ireland, 30 October-1 November 1995.
    J Neurol Sci; 1996 Aug; 139 Suppl():vi, 1-141. PubMed ID: 9019521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.